Oral Delta 9 Tetrahydrocannabinol Chronic Post Traumatic Stress Disorder Study

• $39.95
• 1 mg
• Link.springer.com

Many patients with post-traumatic stress disorder achieve but partial remission with current treatments. This open-label study evaluates the tolerance and safety of orally absorbable Delta 9-tetrahydrocannabinol for chronic PTSD. Ten outpatients with chronic PTSD received 5 mg twice a day as add-on treatment. There were mild adverse effects in three patients. The intervention caused a statistically significant improvement in global symptom severity, sleep quality, frequency of nightmares, and PTSD hyperarousal symptoms.